| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 6.657 | 57.761 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 6.666 | 57.843 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 25.690 | 52.953 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | -19.025 | 4.890 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | -19.091 | 4.357 |
| Employees | - | - | - | - | - | - | - | - | 0 | 1 |
Check the financial reports for the company - Quantusmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 5.576 | 0 |
| Current Assets | - | - | - | - | - | - | - | - | 3.616 | 85.977 |
| Inventories | - | - | - | - | - | - | - | - | 1.579 | 28.142 |
| Receivables | - | - | - | - | - | - | - | - | 1.902 | 23.126 |
| Cash | - | - | - | - | - | - | - | - | 135 | 34.709 |
| Shareholders Funds | - | - | - | - | - | - | - | - | -18.889 | 5.476 |
| Social Capital | - | - | - | - | - | - | - | - | 202 | 20.103 |
| Debts | - | - | - | - | - | - | - | - | 28.081 | 80.501 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Quantusmed S.r.l.